Nikolas T. Martin

1.3k total citations · 1 hit paper
13 papers, 909 citations indexed

About

Nikolas T. Martin is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Nikolas T. Martin has authored 13 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Genetics and 4 papers in Immunology. Recurrent topics in Nikolas T. Martin's work include Virus-based gene therapy research (10 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (3 papers). Nikolas T. Martin is often cited by papers focused on Virus-based gene therapy research (10 papers), CAR-T cell therapy research (10 papers) and Cancer Research and Treatments (3 papers). Nikolas T. Martin collaborates with scholars based in Canada, Germany and United States. Nikolas T. Martin's co-authors include Michael U. Martin, John C. Bell, Marie‐Claude Bourgeois‐Daigneault, Dominic G. Roy, Amelia S. Aitken, David F. Stojdl, Brian D. Lichty, Jean‐Simon Diallo, Guy Ungerechts and Adrian Pelin and has published in prestigious journals such as Nature Communications, Nature Immunology and Biomaterials.

In The Last Decade

Nikolas T. Martin

13 papers receiving 898 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin 33 is a guardian of barriers and a local alarmin

2016 327 citations Nikolas T. Martin, Michael U. Martin Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikolas T. Martin Canada	11	431	429	397	238	142	13	909
Kevin G. Shim United States	13	215 0.5×	374 0.9×	318 0.8×	219 0.9×	40 0.3×	28	634
Pin-Yi Wang United States	14	257 0.6×	331 0.8×	327 0.8×	258 1.1×	44 0.3×	32	792
Mena Mansour United States	11	349 0.8×	684 1.6×	565 1.4×	354 1.5×	96 0.7×	23	1.2k
Jeremy B. Foote United States	18	494 1.1×	255 0.6×	253 0.6×	242 1.0×	330 2.3×	66	1.1k
Cristina Olagüe Spain	14	312 0.7×	284 0.7×	273 0.7×	327 1.4×	29 0.2×	26	821
Sofia V. Gearty United States	5	563 1.3×	257 0.6×	164 0.4×	276 1.2×	91 0.6×	6	1.1k
Meijun Zheng China	12	251 0.6×	501 1.2×	314 0.8×	231 1.0×	19 0.1×	26	806
B.C. Trapnell United States	4	100 0.2×	212 0.5×	526 1.3×	453 1.9×	53 0.4×	9	760
Yan Su United States	19	462 1.1×	204 0.5×	131 0.3×	242 1.0×	52 0.4×	44	987
S Nishikawa Japan	9	476 1.1×	179 0.4×	214 0.5×	341 1.4×	33 0.2×	13	970

Countries citing papers authored by Nikolas T. Martin

Since Specialization

Citations

This map shows the geographic impact of Nikolas T. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolas T. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolas T. Martin more than expected).

Fields of papers citing papers by Nikolas T. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolas T. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolas T. Martin. The network helps show where Nikolas T. Martin may publish in the future.

Co-authorship network of co-authors of Nikolas T. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolas T. Martin. A scholar is included among the top collaborators of Nikolas T. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolas T. Martin. Nikolas T. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Martin, Nikolas T., Mathieu J. F. Crupi, Zaid Taha, et al.. (2023). Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals. 16(5). 709–709. 4 indexed citations

Roy, Dominic G., Monique Marguerie, S. Khan, et al.. (2021). Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. Nature Communications. 12(1). 2626–2626. 51 indexed citations

Martin, Nikolas T., Martin Camiré, & Sara Kramers. (2021). Facilitating life skills transfer from sport to the classroom: An intervention assisting a high school teacher-coach. Journal of Applied Sport Psychology. 34(6). 1077–1101. 8 indexed citations

Azad, Taha, Ragunath Singaravelu, Mathieu J. F. Crupi, et al.. (2020). Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization. Membranes. 10(9). 215–215. 15 indexed citations

Martin, Nikolas T., Dominic G. Roy, Samuel T. Workenhe, et al.. (2019). Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer. Scientific Reports. 9(1). 1865–1865. 22 indexed citations

Woller, Norman, Jennifer D. Brooks, Bettina Fleischmann-Mundt, et al.. (2019). Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nature Communications. 10(1). 3236–3236. 52 indexed citations

Chaurasiya, Shyambabu, Nanhai G. Chen, Jianming Lü, et al.. (2019). A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models. Cancer Gene Therapy. 27(3-4). 125–135. 34 indexed citations

Bourgeois‐Daigneault, Marie‐Claude, Dominic G. Roy, Amelia S. Aitken, et al.. (2018). Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Science Translational Medicine. 10(422). 233 indexed citations

Martin, Nikolas T. & John C. Bell. (2018). Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones. Molecular Therapy. 26(6). 1414–1422. 112 indexed citations

10.

Martin, Nikolas T., Christoph Wrede, Jennifer D. Brooks, et al.. (2017). Targeting polysialic acid-abundant cancers using oncolytic adenoviruses with fibers fused to active bacteriophage borne endosialidase. Biomaterials. 158. 86–94. 11 indexed citations

11.

Aitken, Amelia S., Dominic G. Roy, Nikolas T. Martin, et al.. (2017). Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice. Journal of Immunotherapy. 41(3). 125–129. 14 indexed citations

12.

Martin, Nikolas T. & Michael U. Martin. (2016). Interleukin 33 is a guardian of barriers and a local alarmin. Nature Immunology. 17(2). 122–131. 327 indexed citations breakdown →

13.

Kloos, Arnold, Norman Woller, Engin Gürlevik, et al.. (2015). PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer. Cancer Immunology Research. 3(7). 751–763. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact